Acadian Asset Management
ATRS

Acadian Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Acadian Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-259,336
Closed -$1.03M – 2418
2020
Q4 		$1.03M Sell
259,336
-155,516
-37% -$503K ﹤0.01% 978
2020
Q3 		$1.12M Buy
414,852
+361,648
+680% +$1M ﹤0.01% 866
2020
Q2 		$146K Buy
+53,204
New +$148K ﹤0.01% 1604

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Acadian Asset Management's ATRS Position: Q1 2021 in Review

Acadian Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q1 2021, closing a stake of 259,336 shares — an estimated $1.03M sold.

Acadian Asset Management first reported a position in ATRS in Q2 2020 and held it in 3 quarters. The position peaked at $1.12M in Q3 2020. 171 funds tracked by Wall St. Rank hold ATRS as of Q1 2021.

  • Acadian Asset Management reported no remaining Antares Pharma, Inc. position as of Q1 2021 after selling out during the quarter.
  • Acadian Asset Management sold 259,336 Antares Pharma, Inc. shares in Q1 2021, an estimated $1.03M.
  • Acadian Asset Management first reported a position in Antares Pharma, Inc. in Q2 2020 and held it in 3 quarters.
  • Acadian Asset Management's Antares Pharma, Inc. position peaked at $1.12M in Q3 2020.
  • 171 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2021.

Based on Acadian Asset Management's 13F filing for Q1 2021, filed 11 May 2021.